"V体育2025版" Analysis of Fusion Genes by NanoString System: A Role in Lung Cytology?
- PMID: 29372843
- DOI: 10.5858/arpa.2017-0135-RA
Analysis of Fusion Genes by NanoString System: A Role in Lung Cytology?
Abstract
Context: - Patients with non-small cell lung cancer harboring ALK receptor tyrosine kinase ( ALK), ROS proto-oncogene 1 ( ROS1), and ret proto-oncogene ( RET) gene rearrangements can benefit from specific kinase inhibitors VSports手机版. Detection of fusion genes is critical for determining the best treatment. Assessing rearrangements in non-small cell lung cancer remains challenging, particularly for lung cytology. .
Objective: - To examine the possible application of the multiplex, transcript-based NanoString system (NanoString Technologies, Seattle, Washington) in the evaluation of fusion genes in lung adenocarcinoma samples. V体育安卓版.
Data sources: - This study is a narrative literature review V体育ios版. Studies about NanoString, gene fusions, and lung adenocarcinoma were collected from PubMed (National Center for Biotechnology Information, Bethesda, Maryland). We found 7 articles about the application of the NanoString system to detect fusion genes on formalin-fixed, paraffin-embedded tumor tissues and one article evaluating the adequacy of lung cytologic specimens for NanoString gene expression analysis. .
Conclusions: - To maximize the yield of molecular tests on small lung biopsies, the NanoString nCounter system has been suggested to detect fusion genes. NanoString fusion gene assays have been successfully applied on formalin-fixed, paraffin-embedded tissues. Although there are only a few studies available, the application of NanoString assays may also be feasible in lung cytology VSports最新版本. According to available data, the NanoString system could strengthen the routine molecular characterization of lung adenocarcinoma. .
Comment in
-
NanoString System Versus Multiplex Fluorescent In Situ Hybridization for Gene Fusion Diagnosis in Lung Cancer Cytology Samples: Competing or Complementary Methods?Arch Pathol Lab Med. 2018 Dec;142(12):1451-1452. doi: 10.5858/arpa.2018-0251-LE. Arch Pathol Lab Med. 2018. PMID: 30500277 No abstract available.
-
In Reply.Arch Pathol Lab Med. 2018 Dec;142(12):1452. doi: 10.5858/arpa.2018-0357-LE. Arch Pathol Lab Med. 2018. PMID: 30500281 No abstract available.
Publication types
- Actions (VSports)
"V体育官网入口" MeSH terms
- V体育2025版 - Actions
- "VSports手机版" Actions
- Actions (VSports)
- V体育平台登录 - Actions
- "VSports手机版" Actions
"VSports注册入口" Substances
- Actions (VSports注册入口)
- V体育平台登录 - Actions
- VSports最新版本 - Actions
LinkOut - more resources
Full Text Sources
VSports app下载 - Other Literature Sources
